BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  BioSpace Global Roundup, Aug. 15

  Biopharma companies from across the globe provide updates on their pipeline and business.

  August 14, 2019

   · 

  6 min read

   · 

  Alex Keown
• Policy

  Tomocube Microscope advances Malaria Research

  Label-free, 3-D holotomography imaging enables researchers to observe morphological and chemical alterations of host cells without transfection or dye staining

  August 14, 2019

   · 

  4 min read
• 

  Drug Development

  Regeneron’s Evinacumab Effective in Treating Rare, Inherited High-Cholesterol Disease

  In the trial, evinacumab showed a 49% decrease in LDL cholesterol from baseline compared to placebo, which showed a 2% increase.

  August 14, 2019

   · 

  2 min read

   · 

  Mark Terry
• Pharm Country

  Booming Breakthrough: Creative Biolabs Enables World’s First 100% Identification of Leucine and Isoleucine in De Novo Antibody Sequencing

  It has long been a worldwide problem to precisely identify leucine and isoleucine, not to mention 100% accuracy.

  August 14, 2019

   · 

  4 min read
• Business

  HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights

  HOOKIPA Pharma Inc. reported recent clinical progress highlights and financial results for the second quarter ended June 30, 2019.

  August 14, 2019

   · 

  5 min read
• Policy

  Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Paediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

  Akari Therapeutics, Plc announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for nomacopan for the treatment of hematopoietic stem cell transplant associated thrombotic microangiopathy (HSCT-TMA) in pediatric patients.

  August 14, 2019

   · 

  6 min read
• 

  Policy

  After Two Phase III Successes, Calquence Earns Breakthrough Therapy Designation

  The new designation granted to Calquence marks the 10th such designation the company has earned since 2014, AstraZeneca said.

  August 14, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Pharm Country

  Rutger’s Nanotechnology Research Might Help with Alzheimer’s, Parkinson’s and Other Diseases

  The researchers monitored the creation of neurons from human stem cells by identifying next-generation biomarkers called exosomes.

  August 14, 2019

   · 

  3 min read

   · 

  Mark Terry
• Business

  AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update

  Company Outlines Roadmap to Develop Successful Therapies for Neurodegenerative Diseases Based on its Broad Anti-Tau Clinical Pipeline

  August 14, 2019

   · 

  8 min read
• 

  Lone Star Bio

  Using Nanotube Fibers to Repair Damaged Hearts

  Carbon nanotubes are a type of nanomaterials made up of a two-dimensional lattice of carbon atoms. Researchers at Texas Heart Institute recently used bio-compatible nanotubes invented at Rice University to restore electrical function to damaged hearts.

  August 14, 2019

   · 

  2 min read

   · 

  Mark Terry